Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
I-Chun LaiYi-Wei Chen

Abstract

This study aimed to evaluate the treatment of intracranial nongerminomatous germ cell tumors (NGGCT) and to identify the prognostic factors for survival. Thirty-nine patients with nondisseminated NGGCTs, excluding those with pure mature teratomas, were treated between January 1985 and December 2010. Twenty-four patients received gross total or partial removal, 11 had excision biopsies, and 4 had no surgery. Radiotherapy was given postoperatively or definitively with a median tumor bed dose of 54 Gy (range 30-54) with or without craniospinal irradiation. All patients received ten cycles of adjuvant chemotherapy, vinblastine, bleomycin, etoposide, and cisplatin after radiotherapy, except for one with mixed anaplastic astrocytoma component who received oral temozolomide. Survival and prognostic factors were estimated by the Kaplan-Meier method and log-rank tests, respectively. After a median follow-up of 77.7 months (range 14-336), the 6-year overall survival (OS) and progression-free survival (PFS) were 74.4 and 79.5 %, respectively. Inferior PFS was associated with lesions in the suprasellar region (p = 0.017), poor pathological features (p = 0.048), and with poor image (p < 0.0001) and tumor marker (TM) response (p = 0.003) to ...Continue Reading

References

Apr 1, 1991·Journal of Neurosurgery·H J HoffmanD Jenkin
Aug 1, 1985·Journal of Neurosurgery·M T JenningsF Hochberg
Mar 1, 1997·Journal of Neuro-oncology·P L RobertsonJ C Allen
Apr 21, 1998·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·J U ChoiT S Kim
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MazumdarG J Bosl
Jan 5, 2002·Journal of Neuro-oncology·M Matsutani, UNKNOWN Japanese Pediatric Brain Tumor Study Group
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stewart J KellieJonathan L Finlay
Aug 11, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karim FizaziChristopher J Logothetis
Jul 1, 2008·The Oncologist·Maria E EchevarríaStewart Goldman
Oct 5, 2010·Current Opinion in Neurology·Yuuta Kamoshima, Yutaka Sawamura
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sven-Erik OlofssonEva Cavallin-Ståhl
Oct 30, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MassardK Fizazi
Jul 31, 2013·The Journal of Pediatrics·Roshan V SethiShannon M MacDonald
Feb 1, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MassardK Fizazi

❮ Previous
Next ❯

Citations

May 11, 2018·Journal of Korean Neurosurgical Society·Ji Hoon PhiSeung-Ki Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Related Papers

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
J U ChoiT S Kim
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
K H Carlos ChungRay Chaseling
© 2022 Meta ULC. All rights reserved